A Comprehensive Guide To Medical Device Registration With The Korean FDA (MFDS)

Expanding into South Korea’s highly regulated healthcare market requires a deep understanding of the Ministry of Food and Drug Safety (MFDS) regulatory framework. For global manufacturers, navigating MFDS medical device registration, KGMP certification, and Korea License Holder (KLH) requirements is essential for successful market entry.

This comprehensive 2026 guide by Maven Regulatory Solutions provides a step-by-step breakdown of Korea medical device approval pathways, ensuring compliance with evolving regulatory standards while optimizing time-to-market.

Understanding MFDS Regulatory Framework

The MFDS (formerly Korean FDA) is the central authority responsible for regulating medical devices and in vitro diagnostics (IVDs) in South Korea.

Key regulatory priorities include:

• Device safety and clinical effectiveness 
• Compliance with Korean Good Manufacturing Practice (KGMP) 
• Post-market surveillance and vigilance reporting 
• Harmonization with global regulatory frameworks (US FDA, EU MDR, PMDA) 

Medical Device Classification in South Korea

MFDS classifies devices based on risk level, which directly impacts regulatory requirements and approval timelines.

Step-by-Step MFDS Medical Device Registration Process

Step 1: Device Classification Strategy

Accurate classification is critical for defining:

• Submission pathway 
• Documentation scope 
• Clinical evaluation requirements 

Misclassification can significantly delay MFDS approval timelines.

Step 2: Appoint Korea License Holder (KLH)

Foreign manufacturers must appoint a Korea License Holder (KLH) to:

• Submit regulatory applications 
• Communicate with MFDS 
• Manage post-market compliance 

This is a mandatory requirement for market access in South Korea.

Step 3: Technical Documentation Preparation

Documentation Requirements by Class

Step 4: Type Testing & Performance Evaluation

• Mandatory testing at MFDS-recognized laboratories 
• Acceptance of foreign test reports (in some cases) 
• Performance validation for IVDs and high-risk devices 

Step 5: KGMP Certification (Critical Requirement)

KGMP (Korea Good Manufacturing Practice) certification is mandatory for Class II, III, and IV devices.

Key Elements of KGMP Audit:

• Quality Management System (QMS) compliance 
• Manufacturing process validation 
• Risk management (ISO 14971 alignment) 
• Traceability and CAPA systems 

Step 6: Application Submission To MFDS

The submission includes:

• Administrative documents 
• Technical dossier 
• Clinical evidence (if required) 
• Korean-translated labeling and IFU 

MFDS may issue Deficiency Letters (DLs) requiring clarification or additional data.

Step 7: Approval & Market Authorization

Upon successful review:

• MFDS grants product approval/license 
• Device is listed in Korean medical device registry 
• Manufacturers can legally commercialize the product 

Key Documentation Checklist (All Classes)

• Manufacturer legal details 
• Declaration of Conformity 
• Risk management file 
• Instructions for Use (IFU) in Korean 
• Labeling & packaging compliance 
• Clinical evaluation reports (for high-risk devices) 

MFDS Approval Timelines 

Latest 2026 Regulatory Updates & Trends

To stay competitive in the South Korea medical device market, manufacturers must align with recent MFDS updates:

• Digital Health & SaMD Regulations Expanded 
• Increased focus on cybersecurity compliance for connected devices 
• Integration with IMDRF guidelines 
• Enhanced post-market surveillance requirements 
• Faster pathways for devices approved under US FDA, EU MDR, Japan PMDA 

Expedited Approval Pathways in Korea

Devices may qualify for accelerated MFDS approval if:

• Already approved by US FDA or EU MDR 
• Supported by global clinical data 
• Classified under innovative or breakthrough technologies 

Post-Market Surveillance & Compliance

Post-approval obligations include:

• Adverse event reporting 
• Periodic safety updates 
• License renewals 
• KGMP maintenance audits 

Failure to comply can lead to product recalls or license suspension.

Why Choose Maven Regulatory Solutions?

Maven Regulatory Solutions provides:

• End-to-end MFDS regulatory strategy 
• KLH representation support 
• KGMP audit readiness & compliance 
• Technical documentation & CER preparation 
• Global market entry consulting 

Our expertise ensures faster approvals and seamless compliance in South Korea.

Conclusion

Successfully navigating MFDS medical device registration requires a strategic, well-documented, and compliant approach. From device classification and KLH appointments to KGMP certification and post-market surveillance, each step plays a critical role in achieving market approval.

With increasing regulatory complexity in 2026, partnering with experienced regulatory experts like Maven Regulatory Solutions ensures efficient approvals and sustained compliance in the Korean market.

FAQs 

1. What is MFDS medical device registration?

MFDS registration is the regulatory approval process required to market medical devices in South Korea.

2. Is KGMP certification mandatory for all devices?

No, KGMP is generally required for Class II, III, and IV devices.

3. What is a Korea License Holder (KLH)?

A KLH is a local representative responsible for regulatory communication and compliance with MFDS.

4. How long does MFDS approval take?

Approval timelines range from 1 month (Class I) to 24 months (Class IV).

5. Can foreign clinical data be used for MFDS approval?

Yes, MFDS may accept foreign clinical data depending on device classification and risk level.